Zentiva se hace con aproximadamente el 85,27% de los derechos de voto de APONTIS PHARMA AG

– Zentiva se hace con aproximadamente el 85,27% de los derechos de voto de APONTIS PHARMA AG en el marco de su oferta pública de compra FRANKFURT, Alemania, 26 de noviembre de 2024 /PRNewswire/ — Zentiva AG, filial al 100% de Zentiva Pharma GmbH, con sede en Frankfurt, Alemania, y parte…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.